Excellence United Strategic Alliance to Make North American Debut at INTERPHEX 2012 in New York - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Excellence United Strategic Alliance to Make North American Debut at INTERPHEX 2012 in New York


ePT--the Electronic Newsletter of Pharmaceutical Technology

Excellence United, an alliance of six specialty equipment companies, will make its first North American appearance at INTERPHEX 2012, held May 1–3 at the Javits Center in New York.

The members of Excellence United include: Bausch-Ströbel, Fette Compacting, Glatt, Harro Höfliger, Uhlmann, and Visiotec. Together, these companies comprise more than 4800 people in total with sales in excess of EUR 800 million ($1.05 billion). With the common utilization of resources, customers will have access to an extensive international service network with 600 employees.

The heads of these organizations saw the pharmaceutical industry undergoing a comprehensive transformation process in recent years which presented a wealth of challenges while revealing an opportunity for suppliers to join together to create a comprehensive solution for the pharmaceutical supply chain. The six companies will share a pavilion (booth #1524) at INTERPHEX to kick-off their collaboration in the North American market.

“We are honored that Excellence United will be making INTERPHEX their first stop in North America,” said Bob Stewart, industry vice-president, at INTERPHEX Events. “INTERPHEX is the perfect place to showcase this unique partnership representing the natural evolution of these companies working together.”

All member companies are independent, medium-sized companies, and each one plays an acknowledged technical role as innovators in their respective segment of the market; this is expressed by the name “Excellence United.” Together, the members of the alliance cover all of the stages of the pharmaceutical manufacturing for whom Excellence United offers a unique network in terms of know-how, technology, service, and project management on a worldwide basis.

“Our aim is to take advantage of our joint offerings to significantly improve the productivity and efficiency of our customers’ production, development and packaging processes,” said Uhlmann CEO Siegfried Drost, a spokesperson with Excellence United. “Over the past few years, we’ve practically been passing each other the baton in numerous equipment projects involving operators pursuing a best-in-class approach. By bundling our competencies, we can now offer customers this performance from a single source. They in turn benefit from improved interface management, comprehensive documentation, and on-site support.”

More information can be found here.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here